164 related articles for article (PubMed ID: 26100944)
1. Real-time cancer diagnosis during prostate biopsy: ex vivo evaluation of full-field optical coherence tomography (FFOCT) imaging on biopsy cores.
Lopater J; Colin P; Beuvon F; Sibony M; Dalimier E; Cornud F; Delongchamps NB
World J Urol; 2016 Feb; 34(2):237-43. PubMed ID: 26100944
[TBL] [Abstract][Full Text] [Related]
2. [Full field optical coherence tomography of prostate biopsies: a step towards pre-histological diagnosis?].
Beuvon F; Dalimier E; Cornud F; Barry Delongchamps N
Prog Urol; 2014 Jan; 24(1):22-30. PubMed ID: 24365625
[TBL] [Abstract][Full Text] [Related]
3. Value of Full-Field Optical Coherence Tomography Imaging for the Histological Assessment of Head and Neck Cancer.
De Leeuw F; Abbaci M; Casiraghi O; Ben Lakhdar A; Alfaro A; Breuskin I; Laplace-Builhé C
Lasers Surg Med; 2020 Oct; 52(8):768-778. PubMed ID: 32072655
[TBL] [Abstract][Full Text] [Related]
4. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
5. Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: a prospective study.
Thompson JE; Moses D; Shnier R; Brenner P; Delprado W; Ponsky L; Pulbrook M; Böhm M; Haynes AM; Hayen A; Stricker PD
J Urol; 2014 Jul; 192(1):67-74. PubMed ID: 24518762
[TBL] [Abstract][Full Text] [Related]
6. Manually controlled targeted prostate biopsy with real-time fusion imaging of multiparametric magnetic resonance imaging and transrectal ultrasound: an early experience.
Shoji S; Hiraiwa S; Endo J; Hashida K; Tomonaga T; Nakano M; Sugiyama T; Tajiri T; Terachi T; Uchida T
Int J Urol; 2015 Feb; 22(2):173-8. PubMed ID: 25316213
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of pre-biopsy multiparametric magnetic resonance imaging and clinical variables to reduce initial prostate biopsy in men with suspected clinically localized prostate cancer.
Numao N; Yoshida S; Komai Y; Ishii C; Kagawa M; Kijima T; Yokoyama M; Ishioka J; Matsuoka Y; Koga F; Saito K; Masuda H; Fujii Y; Kawakami S; Kihara K
J Urol; 2013 Aug; 190(2):502-8. PubMed ID: 23473904
[TBL] [Abstract][Full Text] [Related]
8. Qualitative and quantitative assessment of cartilage degeneration using full-field optical coherence tomography ex vivo.
Pailhé R; Mounier A; Boisson B; Rouchy RC; Voros S; Chipon E; Boudry I; Medici M; Hughes C; Moreau-Gaudry A
Osteoarthritis Cartilage; 2018 Feb; 26(2):285-292. PubMed ID: 29162490
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of MRI-Targeted in-Bore Prostate Biopsy According to the Gleason Score with Postprostatectomy Histopathologic Control--a Targeted Biopsy-Only Strategy with Limited Number of Cores.
Garmer M; Busch M; Mateiescu S; Fahlbusch DE; Wagener B; Grönemeyer DH
Acad Radiol; 2015 Nov; 22(11):1409-18. PubMed ID: 26343218
[TBL] [Abstract][Full Text] [Related]
10. Prediction of Significant Prostate Cancer at Prostate Biopsy and Per Core Detection Rate of Targeted and Systematic Biopsies Using Real-Time Shear Wave Elastography.
Boehm K; Budäus L; Tennstedt P; Beyer B; Schiffmann J; Larcher A; Simonis K; Graefen M; Beyersdorff D; Salomon G
Urol Int; 2015; 95(2):189-96. PubMed ID: 26043774
[TBL] [Abstract][Full Text] [Related]
11. Gleason score 7 prostate cancer on needle biopsy: is the prognostic difference in Gleason scores 4 + 3 and 3 + 4 independent of the number of involved cores?
Makarov DV; Sanderson H; Partin AW; Epstein JI
J Urol; 2002 Jun; 167(6):2440-2. PubMed ID: 11992053
[TBL] [Abstract][Full Text] [Related]
12. Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging.
Beyersdorff D; Taupitz M; Winkelmann B; Fischer T; Lenk S; Loening SA; Hamm B
Radiology; 2002 Sep; 224(3):701-6. PubMed ID: 12202702
[TBL] [Abstract][Full Text] [Related]
13. A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial.
Wysock JS; Rosenkrantz AB; Huang WC; Stifelman MD; Lepor H; Deng FM; Melamed J; Taneja SS
Eur Urol; 2014 Aug; 66(2):343-51. PubMed ID: 24262102
[TBL] [Abstract][Full Text] [Related]
14. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies.
Pokorny MR; de Rooij M; Duncan E; Schröder FH; Parkinson R; Barentsz JO; Thompson LC
Eur Urol; 2014 Jul; 66(1):22-9. PubMed ID: 24666839
[TBL] [Abstract][Full Text] [Related]
15. Value of magnetic resonance spectroscopy imaging and dynamic contrast-enhanced imaging for detecting prostate cancer foci in men with prior negative biopsy.
Sciarra A; Panebianco V; Ciccariello M; Salciccia S; Cattarino S; Lisi D; Gentilucci A; Alfarone A; Bernardo S; Passariello R; Gentile V
Clin Cancer Res; 2010 Mar; 16(6):1875-83. PubMed ID: 20197480
[TBL] [Abstract][Full Text] [Related]
16. The value of free and total prostate specific antigen in identifying patients for prostatic biopsy and its relationship to Gleason score and number of positive cores.
Bulbul MA; Khauli RB; Nasr R; Hemady K; Wazzan W
J Med Liban; 2000; 48(2):59-62. PubMed ID: 11028151
[TBL] [Abstract][Full Text] [Related]
17. Improving the Gleason grading accuracy of transrectal ultrasound-guided biopsy.
Nieto-Morales ML; Fernández-Ramos J; Pérez-Méndez L; Alventosa-Fernández E; Pastor-Santoveña MS; Arias-Rodríguez A; Aguirre-Jaime A
Acta Radiol; 2013 Dec; 54(10):1218-23. PubMed ID: 23858506
[TBL] [Abstract][Full Text] [Related]
18. [Prospective validation of a nomogram predictive of a positive initial prostate biopsy].
Ramírez-Backhaus M; Bahilo P; Arlandis S; Santamaría Navarro C; Pontones Moreno JL; Jiménez-Cruz F
Actas Urol Esp; 2010 Jan; 34(1):35-42. PubMed ID: 20223131
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of prostate cancer in patients with persistently elevated PSA and tumor-negative biopsy in ambulatory care: performance of MR imaging in a multi-reader environment.
Scheidler J; Weöres I; Brinkschmidt C; Zeitler H; Panzer S; Scharf M; Heuck A; Siebels M
Rofo; 2012 Feb; 184(2):130-5. PubMed ID: 22274854
[TBL] [Abstract][Full Text] [Related]
20. [Real-time MRI/US fusion-guided biopsy improves detection rates of prostate cancer in pre-biopsied patients].
Maxeiner A; Fischer T; Stephan C; Cash H; Slowinski T; Kilic E; Durmus T
Aktuelle Urol; 2014 May; 45(3):197-203. PubMed ID: 24902069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
